As an alternative to statins, it leverages the synergy of leucine and nicotinic acid with polymethoxylated flavones and tocotrienols to improve lipid biomarkers, fat oxidation, and circadian rhythms. SIRT genes are targeted due to their signaling to regulate fat oxidation, mitochondrial function, inflammatory cytokines, and antioxidant pathways. This axis between SIRT1/NAD+/AMPK is the focus of Sytrinol® LNA and its ability to improve metabolism and dyslipidemia.
